Chemed Cash Flow from Operating Activities 2010-2025 | CHE

Chemed annual/quarterly cash flow from operating activities history and growth rate from 2010 to 2025. Cash flow from operating activities can be defined as a company's cash flows from operations.
  • Chemed cash flow from operating activities for the quarter ending June 30, 2025 was $0.171B, a 5.73% increase year-over-year.
  • Chemed cash flow from operating activities for the twelve months ending June 30, 2025 was $0.874B, a 9.46% increase year-over-year.
  • Chemed annual cash flow from operating activities for 2024 was $0.417B, a 26.4% increase from 2023.
  • Chemed annual cash flow from operating activities for 2023 was $0.33B, a 6.59% increase from 2022.
  • Chemed annual cash flow from operating activities for 2022 was $0.31B, a 0.42% increase from 2021.
Chemed Annual Cash Flow Ops
(Millions of US $)
2024 $417
2023 $330
2022 $310
2021 $309
2020 $489
2019 $301
2018 $287
2017 $162
2016 $135
2015 $172
2014 $110
2013 $151
2012 $132
2011 $174
2010 $86
2009 $161
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $6.639B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.620B 19.70
Encompass Health (EHC) United States $12.443B 24.86
DaVita (DVA) United States $9.826B 14.05
Elanco Animal Health (ELAN) United States $8.674B 19.40
RadNet (RDNT) United States $5.280B 190.67
Option Care Health (OPCH) United States $4.418B 18.90
Addus HomeCare (ADUS) United States $2.114B 22.79
LifeStance Health (LFST) United States $2.081B 0.00
Astrana Health (ASTH) United States $1.632B 57.08
Aveanna Healthcare Holdings (AVAH) United States $1.504B 27.69
U.S Physical Therapy (USPH) United States $1.279B 31.98
Pennant (PNTG) United States $0.870B 30.68
Atai Life Sciences (ATAI) Germany $0.851B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.052B 0.00
Daxor (DXR) United States $0.052B 0.00
Psychemedics (PMD) United States $0.000B 0.00